Thursday, 11 December 2003
Sheraton Boston Hotel Grand Ballroom (1100)
CESS-81-119

This presentation is part of CESS-81. Poster Session

Adoption of Tobacco Treatment by Substance Abuse Treatment Clinicians

Karen B. Friend, PhD, Pacific Institute for Research & Evaluation, Decision Sciences Institute, Karen_Friend@brown.edu, David T. Levy, PhD, levy@pire.org, Robert Swift, MD PhD, Robert_Swift@brown.edu, Christopher Kahler, PhD, Christopher_Kahler@brown.edu, Charles Neighbors, PhD, cneighbors1@lifespan.org, Cindy Parks Thomas, PhD, cthomas@brandeis.edu.

Learning Objectives: Indentify the barriers to and facilitators of the adoption of tobacco treatment interventions by substance abuse treatment clinicians

Abstract: Adoption of Tobacco Treatment by Substance Abuse Treatment Clinicians


Problem/Objective:
Patients in treatment for substance use disorders tend to smoke at higher rates than the general population and are more likely to die from tobacco use than from the substance(s) for which they are seeking treatment. However, despite the fact such patients may be interested in smoking cessation and can quit successfully without jeopardizing their sobriety, clinicians are often reluctant to advise their patients to stop smoking. The purpose of this presentation is to review barriers to and facilitators of the adoption of tobacco treatment interventions (TTIs) by substance abuse treatment clinicians and to determine where interventions to increase TTI use should be targeted.

Method: We systematically searched MEDLINE and PSYCHINFO for papers written between 1980-present. We paid particular attention to better quality studies that included comparison or control groups and used empirically-sound methodologies.


Results:
We conclude that obstacles to TTI adoption involve the interaction of individual clinician, organizational, and environmental factors, and that changes in all three are needed to increase TTI adoption among substance abuse treatment clinicians.


Conclusions:
Future research is warranted that comprehensively assess individual clinician, organizational, and, in particular, environmental factors associated with TTI adoption. Studies are also needed to help determine how to increase the clinical applicability of empirical findings on obstacles to TTI adoption to bridge the gap between research and clinical practice.


Back to Poster Session
Back to Cessation, Nicotine, and the Science of Addiction

Back to The 2003 National Conference on Tobacco or Health (December 10-12, 2003)